References
  1. Almanzar, G., B. Ottensmeier, J. Liese and M. Prelog (2013). Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. J Immunol Methods 387(1-2): 36-42.DOI: 10.1016/j.jim.2012.09.008.
  2. Baron, R. C., L. Risch, M. Weber, S. Thiel, K. Grossmann, N. Wohlwend, T. Lung, D. Hillmann, M. Ritzler, S. Bigler, K. Egli, F. Ferrara, T. Bodmer, M. Imperiali, S. Heer, H. Renz, L. Flatz, P. Kohler, P. Vernazza, C. R. Kahlert, M. Paprotny and M. Risch (2020). Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study. Clin Chem Lab Med58(12): 2131-2140.DOI: 10.1515/cclm-2020-0978.
  3. Bartlam, M., H. Yang and Z. Rao (2005). Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol 15(6): 664-672.DOI: 10.1016/j.sbi.2005.10.004.
  4. Callow, K. A. (1985). Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg (Lond) 95(1): 173-189.DOI: 10.1017/s0022172400062410.
  5. Devito, C., J. Hinkula, R. Kaul, L. Lopalco, J. J. Bwayo, F. Plummer, M. Clerici and K. Broliden (2000). Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14(13): 1917-1920.DOI: 10.1097/00002030-200009080-00006.
  6. Grifoni, A., D. Weiskopf, S. I. Ramirez, J. Mateus, J. M. Dan, C. R. Moderbacher, S. A. Rawlings, A. Sutherland, L. Premkumar, R. S. Jadi, D. Marrama, A. M. de Silva, A. Frazier, A. F. Carlin, J. A. Greenbaum, B. Peters, F. Krammer, D. M. Smith, S. Crotty and A. Sette (2020). Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181(7): 1489-1501 e1415.DOI: 10.1016/j.cell.2020.05.015.
  7. Jaaskelainen, A. E., M. J. Ahava, P. Jokela, L. Szirovicza, S. Pohjala, O. Vapalahti, M. Lappalainen, J. Hepojoki and S. Kurkela (2021). Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol 137: 104785.DOI: 10.1016/j.jcv.2021.104785.
  8. Kneitz, R. H., J. Schubert, F. Tollmann, W. Zens, K. Hedman and B. Weissbrich (2004). A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.BMC Infect Dis 4: 33.DOI: 10.1186/1471-2334-4-33.
  9. Le Bert, N., A. T. Tan, K. Kunasegaran, C. Y. L. Tham, M. Hafezi, A. Chia, M. H. Y. Chng, M. Lin, N. Tan, M. Linster, W. N. Chia, M. I. Chen, L. F. Wang, E. E. Ooi, S. Kalimuddin, P. A. Tambyah, J. G. Low, Y. J. Tan and A. Bertoletti (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.Nature 584(7821): 457-462.DOI: 10.1038/s41586-020-2550-z.
  10. Long, Q. X., B. Z. Liu, H. J. Deng, G. C. Wu, K. Deng, Y. K. Chen, P. Liao, J. F. Qiu, Y. Lin, X. F. Cai, D. Q. Wang, Y. Hu, J. H. Ren, N. Tang, Y. Y. Xu, L. H. Yu, Z. Mo, F. Gong, X. L. Zhang, W. G. Tian, L. Hu, X. X. Zhang, J. L. Xiang, H. X. Du, H. W. Liu, C. H. Lang, X. H. Luo, S. B. Wu, X. P. Cui, Z. Zhou, M. M. Zhu, J. Wang, C. J. Xue, X. F. Li, L. Wang, Z. J. Li, K. Wang, C. C. Niu, Q. J. Yang, X. J. Tang, Y. Zhang, X. M. Liu, J. J. Li, D. C. Zhang, F. Zhang, P. Liu, J. Yuan, Q. Li, J. L. Hu, J. Chen and A. L. Huang (2020). Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26(6): 845-848.DOI: 10.1038/s41591-020-0897-1.
  11. Long, Q. X., X. J. Tang, Q. L. Shi, Q. Li, H. J. Deng, J. Yuan, J. L. Hu, W. Xu, Y. Zhang, F. J. Lv, K. Su, F. Zhang, J. Gong, B. Wu, X. M. Liu, J. J. Li, J. F. Qiu, J. Chen and A. L. Huang (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.Nat Med 26(8): 1200-1204.DOI: 10.1038/s41591-020-0965-6.
  12. Marian, A. J. (2021). Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.Cardiovasc Pathol 50: 107278.DOI: 10.1016/j.carpath.2020.107278.
  13. Marklund, E., S. Leach, H. Axelsson, K. Nystrom, H. Norder, M. Bemark, D. Angeletti, A. Lundgren, S. Nilsson, L. M. Andersson, A. Yilmaz, M. Lindh, J. A. Liljeqvist and M. Gisslen (2020). Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders. PLoS One 15(10): e0241104.DOI: 10.1371/journal.pone.0241104.
  14. Moldoveanu, Z., M. L. Clements, S. J. Prince, B. R. Murphy and J. Mestecky (1995). Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13(11): 1006-1012.DOI: 10.1016/0264-410x(95)00016-t.
  15. Planque, S., M. Salas, Y. Mitsuda, M. Sienczyk, M. A. Escobar, J. P. Mooney, M. K. Morris, Y. Nishiyama, D. Ghosh, A. Kumar, F. Gao, C. V. Hanson and S. Paul (2010). Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection. AIDS 24(6): 875-884.DOI: 10.1097/QAD.0b013e3283376e88.
  16. Pradenas, E., B. Trinite, V. Urrea, S. Marfil, C. Avila-Nieto, M. L. Rodriguez de la Concepcion, F. Tarres-Freixas, S. Perez-Yanes, C. Rovirosa, E. Ainsua-Enrich, J. Rodon, J. Vergara-Alert, J. Segales, V. Guallar, A. Valencia, N. Izquierdo-Useros, R. Paredes, L. Mateu, A. Chamorro, M. Massanella, J. Carrillo, B. Clotet and J. Blanco (2021). Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y) 2(3): 313-320 e314.DOI: 10.1016/j.medj.2021.01.005.
  17. Prelog, M., G. Almanzar, N. Rieber, B. Ottensmeier, M. Zlamy and J. Liese (2013). Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine 31(2): 387-393.DOI: 10.1016/j.vaccine.2012.10.105.
  18. Prelog, M., J. Schonlaub, V. Jeller, G. Almanzar, K. Hofner, S. Gruber, T. Eiwegger and R. Wurzner (2013). Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine 31(20): 2420-2426.DOI: 10.1016/j.vaccine.2013.03.058.
  19. Shang, J., G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach and F. Li (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature 581(7807): 221-224.DOI: 10.1038/s41586-020-2179-y.
  20. Sonnleitner, S. T., M. Prelog, B. Jansen, C. Rodgarkia-Dara, S. Gietl, C. M. Schonegger, S. Koblmuller, C. Sturmbauer, W. Posch, G. Almanzar, H. Jury, T. Loney, A. Tichy, N. Nowotny and G. Walder (2021). Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transbound Emerg Dis .DOI: 10.1111/tbed.14130.
  21. Sterlin, D., A. Mathian, M. Miyara, A. Mohr, F. Anna, L. Claer, P. Quentric, J. Fadlallah, H. Devilliers, P. Ghillani, C. Gunn, R. Hockett, S. Mudumba, A. Guihot, C. E. Luyt, J. Mayaux, A. Beurton, S. Fourati, T. Bruel, O. Schwartz, J. M. Lacorte, H. Yssel, C. Parizot, K. Dorgham, P. Charneau, Z. Amoura and G. Gorochov (2021). IgA dominates the early neutralizing antibody response to SARS-CoV-2.Sci Transl Med 13(577).DOI: 10.1126/scitranslmed.abd2223.
  22. Stromer, A., R. Rose, O. Grobe, F. Neumann, H. Fickenscher, T. Lorentz and A. Krumbholz (2020). Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection. Microorganisms 8(10).DOI: 10.3390/microorganisms8101572.
  23. Tretyn, A., J. Szczepanek, M. Skorupa, J. Jarkiewicz-Tretyn, D. Sandomierz, J. Dejewska, K. Ciechanowska, A. Jarkiewicz-Tretyn, W. Koper and K. Palgan (2021). Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination. Cells 10(8).DOI: 10.3390/cells10081952.
  24. Weiskopf, D., K. S. Schmitz, M. P. Raadsen, A. Grifoni, N. M. A. Okba, H. Endeman, J. P. C. van den Akker, R. Molenkamp, M. P. G. Koopmans, E. C. M. van Gorp, B. L. Haagmans, R. L. de Swart, A. Sette and R. D. de Vries (2020). Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.Sci Immunol 5(48).DOI: 10.1126/sciimmunol.abd2071.
  25. Woof, J. M. and M. A. Kerr (2006). The function of immunoglobulin A in immunity. J Pathol 208(2): 270-282.DOI: 10.1002/path.1877.
  26. Zhang, Y., Y. Li, L. Wang, M. Li and X. Zhou (2020). Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China. Int J Environ Res Public Health17(10).DOI: 10.3390/ijerph17103705.
  27. Zhou, P., X. L. Yang, X. G. Wang, B. Hu, L. Zhang, W. Zhang, H. R. Si, Y. Zhu, B. Li, C. L. Huang, H. D. Chen, J. Chen, Y. Luo, H. Guo, R. D. Jiang, M. Q. Liu, Y. Chen, X. R. Shen, X. Wang, X. S. Zheng, K. Zhao, Q. J. Chen, F. Deng, L. L. Liu, B. Yan, F. X. Zhan, Y. Y. Wang, G. F. Xiao and Z. L. Shi (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798): 270-273.DOI: 10.1038/s41586-020-2012-7.